New York State Common Retirement Fund’s Blueprint Medicines BPMC Stock Holding History

New York State Common Retirement Fund’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,920	Closed	-$2.68M	–	3190
2025 Q2	$2.68M	Buy	20,920 +1,100	+6%	+$114K	﹤0.01%	1307
2025 Q1	$1.75M	Buy	19,820 +300	+2%	+$29.3K	﹤0.01%	1427
2024 Q4	$1.7M	Hold	19,520	–	–	﹤0.01%	1474
2024 Q3	$1.81M	Sell	19,520 -13,175	-40%	-$1.31M	﹤0.01%	1442
2024 Q2	$3.52M	Sell	32,695 -4,082	-11%	-$409K	﹤0.01%	1270
2024 Q1	$3.49M	Buy	36,777 +2,351	+7%	+$202K	﹤0.01%	1255
2023 Q4	$3.18M	Sell	34,426 -2,648	-7%	-$172K	﹤0.01%	1277
2023 Q3	$1.86M	Buy	37,074 +2,078	+6%	+$111K	﹤0.01%	1478
2023 Q2	$2.21M	Sell	34,996 -6,929	-17%	-$377K	﹤0.01%	1459
2023 Q1	$1.89M	Sell	41,925 -10,650	-20%	-$480K	﹤0.01%	1569
2022 Q4	$2.3M	Buy	52,575 +2,796	+6%	+$134K	﹤0.01%	1568
2022 Q3	$3.28M	Buy	49,779 +5,121	+11%	+$329K	﹤0.01%	1365
2022 Q2	$2.26M	Sell	44,658 -5,820	-12%	-$341K	﹤0.01%	1591
2022 Q1	$3.23M	Buy	50,478 +2,042	+4%	+$147K	﹤0.01%	1505
2021 Q4	$5.19M	Sell	48,436 -226	-0.5%	-$23.6K	0.01%	1282
2021 Q3	$5M	Sell	48,662 -9,261	-16%	-$862K	0.01%	1323
2021 Q2	$5.09M	Sell	57,923 -27	-0%	-$2.47K	0.01%	1331
2021 Q1	$5.63M	Hold	57,950	–	–	0.01%	1219
2020 Q4	$6.5M	Sell	57,950 -250	-0.4%	-$26.3K	0.01%	1143
2020 Q3	$5.39M	Buy	58,200 +900	+2%	+$69.3K	0.01%	1134
2020 Q2	$4.47M	Buy	57,300 +8,700	+18%	+$588K	0.01%	1200
2020 Q1	$2.84M	Buy	48,600 +4,700	+11%	+$302K	﹤0.01%	1268
2019 Q4	$3.52M	Sell	43,900 -7,100	-14%	-$532K	﹤0.01%	1373
2019 Q3	$3.75M	Sell	51,000 -3,312	-6%	-$286K	﹤0.01%	1347
2019 Q2	$5.12M	Buy	54,312 +3,235	+6%	+$267K	0.01%	1251
2019 Q1	$4.09M	Buy	51,077 +10,477	+26%	+$774K	0.01%	1325
2018 Q4	$2.19M	Sell	40,600 -9,486	-19%	-$577K	﹤0.01%	1509
2018 Q3	$3.91M	Hold	50,086	–	–	﹤0.01%	1373
2018 Q2	$3.18M	Sell	50,086 -5,563	-10%	-$443K	﹤0.01%	1451
2018 Q1	$5.1M	Buy	55,649 +4,615	+9%	+$398K	0.01%	1229
2017 Q4	$3.85M	Buy	51,034 +2,527	+5%	+$178K	﹤0.01%	1335
2017 Q3	$3.38M	Buy	48,507 +3,835	+9%	+$205K	﹤0.01%	1382
2017 Q2	$2.26M	Buy	44,672 +22,289	+100%	+$946K	﹤0.01%	1606
2017 Q1	$895K	Buy	22,383 +1,883	+9%	+$67.4K	﹤0.01%	2084
2016 Q4	$575K	Hold	20,500	–	–	﹤0.01%	2314
2016 Q3	$609K	Hold	20,500	–	–	﹤0.01%	2216
2016 Q2	$415K	Buy	20,500 +10,200	+99%	+$185K	﹤0.01%	2354
2016 Q1	$186K	Hold	10,300	–	–	﹤0.01%	2707
2015 Q4	$271K	Hold	10,300	–	–	﹤0.01%	2605
2015 Q3	$220K	Buy	10,300 +4,209	+69%	+$116K	﹤0.01%	2740
2015 Q2	$161K	Buy	+6,091	New	+$174K	﹤0.01%	2990

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

New York State Common Retirement Fund's BPMC Position: Q3 2025 in Review

New York State Common Retirement Fund sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 20,920 shares — an estimated $2.68M sold.

New York State Common Retirement Fund first reported a position in BPMC in Q2 2015 and held it in 41 quarters. The position peaked at $6.5M in Q4 2020. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

New York State Common Retirement Fund reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
New York State Common Retirement Fund sold 20,920 Blueprint Medicines shares in Q3 2025, an estimated $2.68M.
New York State Common Retirement Fund first reported a position in Blueprint Medicines in Q2 2015 and held it in 41 quarters.
New York State Common Retirement Fund's Blueprint Medicines position peaked at $6.5M in Q4 2020.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on New York State Common Retirement Fund's 13F filing for Q3 2025, filed 3 Nov 2025.